The rationale for targeting the LOX family in cancer, Nature Reviews Cancer, vol.12, issue.8, pp.540-552, 2012. ,
DOI : 10.1038/nrc3319
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution, Cancer Research, vol.71, issue.5, pp.1561-1572, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-2868
Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK, Oncogene, vol.25, issue.14, pp.1863-1868, 2013. ,
DOI : 10.1038/onc.2012.202
LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis, Cancer Research, vol.73, issue.6, pp.1721-1732, 2013. ,
DOI : 10.1158/0008-5472.CAN-12-2233
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling, Cell, vol.139, issue.5, pp.891-906, 2009. ,
DOI : 10.1016/j.cell.2009.10.027
Type I collagen: Structure, synthesis and regulation ,
Potential options for managing LOX+ ER- breast cancer patients, Oncotarget, vol.7, pp.32893-32901, 2016. ,
DOI : 10.18632/oncotarget.9073
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, vol.5, issue.4, pp.329-339, 2004. ,
DOI : 10.1016/S1535-6108(04)00081-9
Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment, Cancer Research, vol.70, issue.14, pp.5706-5716, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-2356
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436125